Abstract

BackgroundIn early breast cancer, the optimal technique for sentinel lymph node biopsy (SLNB) is the combined technique (radioisotope and Patent Blue V) which achieves high identification rates. Despite this, many centres have decided to stop using blue dye due to blue-dye-related complications (tattoo, anaphylaxis). We evaluated the SLNB identification rate using the combined technique with and without Patent Blue V and the blue-dye-related complication rates.MethodsClinical and histological data were analysed on patients undergoing SLNB between March 2014 and April 2015. SLNB was performed following standard hospital protocols using the combined technique.ResultsA total of 208 patients underwent SLNB and 160 patients (342 nodes) with complete operation notes were available for final analysis. The identification rate with the combined technique was 98.8% (n = 158/160), with blue dye alone 92.5% (n = 148/160) and with radioisotope alone 97.5% (n = 156/160). A total of 76.9% (263/342) of nodes were radioactive and blue, 15.5% (53/342) only radioactive and 2.3% (8/342) only blue, 5.3% (18/342) were neither radioactive nor blue. No anaphylactic reactions were reported and blue skin staining was reported in six (3.8%) patients.ConclusionThe combined technique should continue be the preferred technique for SLNB and should be standardised. Radioisotope alone (but not blue dye alone) has comparable sentinel node identification rates in experienced hands. National guidelines are required to optimise operative documentation.

Highlights

  • In early breast cancer, sentinel lymph node biopsy (SLNB) is the preferred method for axillary staging [1,2]

  • It is well known that use of the combination of radioisotope and blue dye is significantly better than the two tracers in isolation [7,8,9]

  • We evaluated the SLNB identification rate in experienced hands using the combined technique with and without Patent Blue V and the blue-dye-related complication rates

Read more

Summary

Introduction

Sentinel lymph node biopsy (SLNB) is the preferred method for axillary staging [1,2]. We evaluated the SLNB identification rate in experienced hands using the combined technique with and without Patent Blue V and the blue-dye-related complication rates. The optimal technique for sentinel lymph node biopsy (SLNB) is the combined technique (radioisotope and Patent Blue V) which achieves high identification rates. We evaluated the SLNB identification rate using the combined technique with and without Patent Blue V and the blue-dye-related complication rates. The identification rate with the combined technique was 98.8% (n = 158/160), with blue dye alone 92.5% (n = 148/160) and with radioisotope alone 97.5% (n = 156/160). Radioisotope alone (but not blue dye alone) has comparable sentinel node identification rates in experienced hands.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.